Safety and Efficacy of Nusinersen and Risdiplam for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

被引:6
作者
Qiao, Yue [1 ]
Chi, Yuewei [1 ]
Gu, Jian [1 ]
Ma, Ying [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Neurol, Shenyang 110055, Peoples R China
关键词
spinal muscular atrophy; nusinersen; risdiplam; meta-analysis; efficacy; safety; MOTOR FUNCTION; SHAM CONTROL; THERAPIES; SMA;
D O I
10.3390/brainsci13101419
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: We performed a systematic review and meta-analysis of the efficacy and safety of nusinersen and risdiplam in the treatment of spinal muscular disease (SMA). Methods: We screened the literature published in Pubmed, Web of Science, Embase, and Cochrane before July 2023 to conduct randomized controlled trials to test the treatment of SMA patients with nusinersen and risdiplam. The data were analyzed using Review Manager 5.4 software and Stata version 15.0 software. Results: A total of six randomized controlled trials were included, involving 728 SMA patients, to synthesize evidence. It is reported that nusinersen treatment was beneficial for increasing the score of the Hammersmith Functional Motor Scale-Expanded (HFMSE) (WMD: 4.90; 95% CI: 3.17, 6.63; p < 0.00001), Revised Upper Limb Module (RULM) (WMD: 3.70; 95% CI: 3.30, 4.10; p < 0.00001), and Hammersmith Infant Neurological Evaluation Section 2 (HINE-2) (WMD: 5.21; 95% CI: 4.83, 5.60; p < 0.00001). In addition, the risdiplam treatment group also showed statistically significant improvements in the HFMSE score (WMD:0.87; 95% CI: 0.05, 1.68; p = 0.04), the 32-item Motor Function Measure (MFM32) (WMD:1.48; 95% CI: 0.58, 2.38; p = 0.001), and (WMD: 1.29; 95% CI: 0.57, 2.01; p = 0.0005). Nusinersen and risdiplam did not cause a statistically significant increase in the RULM score for adverse events (OR: 0.93; 95% CI: 0.51, 1.7; p = 0.82) and for severe adverse events (OR: 0.77; 95% CI: 0.47, 1.27; p = 0.31). Conclusion: Our analysis found that nusinersen and risdiplam treatment showed clinically meaningful improvement in motor function and a similar incidence rate of adverse events compared with the placebo. Further research should be carried out to provide a direct comparison between the two drugs in terms of safety and efficacy.
引用
收藏
页数:13
相关论文
共 50 条
[41]   Reply to Aljabali et al. Comment on "Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213" [J].
Abdelazeem, Basel ;
Abbas, Kirellos Said ;
Brasic, James Robert .
MEDICINA-LITHUANIA, 2022, 58 (06)
[42]   Safety, tolerability, and efficacy of a widely available nusinersen program for Polish children with Spinal Muscular Atrophy [J].
Kotulska, Katarzyna ;
Chmielewski, Dariusz ;
Mazurkiewicz-Beldzinska, Maria ;
Tomaszek, Katarzyna ;
Pierzchlewicz, Katarzyna ;
Rabczenko, Daniel ;
Przyslo, Lukasz ;
Biedro, Agnieszka ;
Czyzyk, Elzbieta ;
Steinborn, Barbara ;
Pietruszewski, Jerzy ;
Bockowski, Leszek ;
Cichosz, Dorota ;
Dudzinska, Magdalena ;
Gadowska, Elzbieta ;
Mlynarczyk, Elzbieta ;
Jasinski, Miroslaw ;
Masztalerz, Anna ;
Kempisty, Agnieszka ;
Kostera-Pruszczyk, Anna .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2022, 39 :103-109
[43]   Analysis of the efficacy and adverse effects of nusinersen in the treatment of children with spinal muscular atrophy in China [J].
Li, Dan ;
Yang, Jie ;
Wang, Xueying ;
Yang, Lin ;
Luo, Rong ;
Huang, Shaoping .
BRAIN AND BEHAVIOR, 2024, 14 (07)
[44]   Nusinersen treatment of spinal muscular atrophy - a systematic review [J].
Albrechtsen, Simon Sander ;
Born, Alfred Peter ;
Boesen, Magnus Spangsberg .
DANISH MEDICAL JOURNAL, 2020, 67 (09)
[45]   Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials [J].
Fu, Xi ;
Ye, Xin ;
An, Li-Na ;
Jiang, Hua ;
Huang, Wen-Bo ;
Huang, Ya ;
Dong, Jing ;
Ren, Yi-Feng .
PAIN AND THERAPY, 2023, 12 (01) :165-186
[46]   Efficacy and safety of acupuncture for perimenopausal insomnia: A systematic review and meta-analysis of randomized controlled trials [J].
Qin, Luquan ;
Zhang, Zhiyu ;
Zhang, Chuanfang ;
Zhou, Hua .
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2024, 72
[47]   Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials [J].
Thadanipon, Kunlawat ;
Anothaisintawee, Thunyarat ;
Rattanasiri, Sasivimol ;
Thakkinstian, Ammarin ;
Attia, John .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (05) :1435-1444
[48]   Efficacy and safety of Mirikizumab for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials [J].
Mohamed A. Abu Elainein ;
Sama S. ElSherefy ;
Norhan M. Yousef ;
Sama M. ElKady ;
Nada G. Hamam ;
Abdullrahman Elgarawany ;
Darin W. Aswa ;
Ahmed Nour Eldin Hassan ;
Salma Allam .
BMC Gastroenterology, 25 (1)
[49]   Efficacy and Safety of Eucalyptus for Relieving Cough: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J].
Her, Ladda ;
Kanjanasilp, Juntip ;
Chaiyakunapruk, Nathorn ;
Sawangjit, Ratree .
JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2022, 28 (03) :218-226
[50]   Safety and efficacy of Simvastatin in the treatment of vitiligo: a systematic review and meta-analysis of randomized controlled trials [J].
Song Zhang ;
Ibrahim Serag ;
Shereen Mohamed Olama ;
Mahmoud G. A. Saleh ;
E. A. Shaban ;
Mostafa Hossam El Din Moawad .
Archives of Dermatological Research, 317 (1)